Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
57.73
-1.97 (-3.30%)
At close: Mar 6, 2026, 4:00 PM EST
58.28
+0.55 (0.95%)
After-hours: Mar 6, 2026, 6:49 PM EST

Structure Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Selling, General & Admin
61.5549.4132.6716.378.59
Upgrade
Research & Development
225.26108.8170.136.1929.11
Upgrade
Other Operating Expenses
-100----
Upgrade
Operating Expenses
186.81158.23102.7852.5637.7
Upgrade
Operating Income
-186.81-158.23-102.78-52.56-37.7
Upgrade
Interest Expense
-----0.12
Upgrade
Interest & Investment Income
35.8736.0113.391.26-
Upgrade
EBT Excluding Unusual Items
-150.94-122.22-89.38-51.3-37.82
Upgrade
Gain (Loss) on Sale of Assets
10.25----
Upgrade
Pretax Income
-140.69-122.22-89.38-51.3-37.82
Upgrade
Income Tax Expense
0.520.310.240.020.23
Upgrade
Net Income
-141.2-122.53-89.62-51.32-38.05
Upgrade
Preferred Dividends & Other Adjustments
---1.525.72
Upgrade
Net Income to Common
-141.2-122.53-89.62-52.84-43.77
Upgrade
Shares Outstanding (Basic)
59533733
Upgrade
Shares Outstanding (Diluted)
59533733
Upgrade
Shares Change (YoY)
12.46%43.31%1049.81%17.72%30.01%
Upgrade
EPS (Basic)
-2.39-2.33-2.44-16.54-16.13
Upgrade
EPS (Diluted)
-2.39-2.33-2.44-16.54-16.13
Upgrade
Free Cash Flow
-225.81-117.93-81.66-46.28-33.37
Upgrade
Free Cash Flow Per Share
-3.81-2.24-2.22-14.48-12.30
Upgrade
EBITDA
-185.13-157.23-102.46-52.28-37.62
Upgrade
D&A For EBITDA
1.6810.320.280.07
Upgrade
EBIT
-186.81-158.23-102.78-52.56-37.7
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.